SEYSARA Trademark

Trademark Overview

On Thursday, June 2, 2016, a trademark application was filed for SEYSARA with the United States Patent and Trademark Office. The USPTO has given the SEYSARA trademark a serial number of 87058418. The federal status of this trademark filing is REGISTERED as of Tuesday, April 30, 2019. This trademark is owned by Allergan Pharmaceuticals International Limited. The SEYSARA trademark is filed in the Pharmaceutical Products category with the following description:

Oral pharmaceutical preparations for the treatment of acne
seysara

General Information

Serial Number87058418
Word MarkSEYSARA
Filing DateThursday, June 2, 2016
Status700 - REGISTERED
Status DateTuesday, April 30, 2019
Registration Number5740134
Registration DateTuesday, April 30, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2016

Trademark Statements

Goods and ServicesOral pharmaceutical preparations for the treatment of acne
Translation of Words in MarkThe wording "SEYSARA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 10, 2016
Primary Code005
First Use Anywhere DateWednesday, December 5, 2018
First Use In Commerce DateThursday, January 10, 2019

Trademark Owner History

Party NameALMIRALL, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressMalvern, PA 19355
Party NameALMIRALL, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressEXTON, PA 19341
Party NameAllergan Pharmaceuticals International Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCoolock, Dubin 17
IE
Party NameAllergan Pharmaceuticals International Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCoolock, Dubin 17
IE

Trademark Events

Event DateEvent Description
Wednesday, March 30, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 30, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 30, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 30, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 30, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 30, 2019REGISTERED-PRINCIPAL REGISTER
Saturday, March 23, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, March 22, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 7, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 13, 2019USE AMENDMENT FILED
Thursday, March 7, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 13, 2019TEAS STATEMENT OF USE RECEIVED
Saturday, December 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 13, 2018EXTENSION 4 GRANTED
Thursday, December 13, 2018EXTENSION 4 FILED
Thursday, December 13, 2018TEAS EXTENSION RECEIVED
Wednesday, December 12, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 12, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 10, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, June 13, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 11, 2018EXTENSION 3 GRANTED
Monday, June 11, 2018EXTENSION 3 FILED
Monday, June 11, 2018TEAS EXTENSION RECEIVED
Friday, November 3, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 1, 2017EXTENSION 2 GRANTED
Wednesday, November 1, 2017EXTENSION 2 FILED
Wednesday, November 1, 2017TEAS EXTENSION RECEIVED
Tuesday, May 9, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 5, 2017EXTENSION 1 GRANTED
Friday, May 5, 2017EXTENSION 1 FILED
Friday, May 5, 2017TEAS EXTENSION RECEIVED
Tuesday, January 17, 2017ASSIGNED TO EXAMINER
Tuesday, December 20, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 25, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2016PUBLISHED FOR OPPOSITION
Wednesday, October 5, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 19, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 14, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 14, 2016EXAMINER'S AMENDMENT ENTERED
Tuesday, September 13, 2016ASSIGNED TO LIE
Tuesday, September 13, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 13, 2016EXAMINERS AMENDMENT E-MAILED
Tuesday, September 13, 2016EXAMINERS AMENDMENT -WRITTEN
Friday, September 2, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 2, 2016NON-FINAL ACTION E-MAILED
Friday, September 2, 2016NON-FINAL ACTION WRITTEN
Thursday, September 1, 2016ASSIGNED TO EXAMINER
Friday, June 10, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 6, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

seysara acne treatment preparations pharmaceutical oral